header
Local cover image
Local cover image
Image from OpenLibrary

Comparative hepatoprotective efficacy of some anti-oxidants and prebiotics on experimentally induced hepatic fibrosis in rats / Zeinab Adel Mahmoud Elgendy ; Supervised Salah Eldin Abdelhamid Youssef , Amer Ramadan Ali Ayad , Seham Abdelsatar Elbatran

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Zeinab Adel Mahmoud Elgendy , 2021Description: 81 P. : charts , facsimiles ; 25cmOther title:
  • دراسة مقارنة عن الفعالية الوقائية لبعض مضادات الأكسدة والبريبيوتكس على التليف الكبدى المستحدث تجريبيا فى الجرذان [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Veterinary Medicine - Department of Veterinary Pharmacology Summary: Fibrosis represents a common outcome of almost all chronic liver diseases and leads to an impairment of liver function that requires medical intervention. The current study aimed at evaluating the potential anti- fibrotic activity of saccharomyces cervisciae cell wall extract (SCCWE) and carvacrol against thioacetamide (TAA)-induced liver fibrosis in rats (200mg/ kg b.w. i.p. twice weekly for 6 weeks) using ursodeoxycholic acid (UDCA) (20 mg/kg p.o.) as a reference anti-fibrotic product. SCCWE at two doses (50 and 100 mg/kg) and carvacrol at two doses (25 and 50 mg/ kg p.o.) significantly ameliorated the rise in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamide transferase (GGT), total bilirubin (TB) and direct bilirubin (DB) and increased total protein (TP) and albumin level. SCCWE significantly reduced glutathione depletion (GSH), nitric oxide (NOX) and malondialdehyde (MDA) accumulation in liver tissue. Its anti-oxidant effects appeared by affecting markers of stress found in the cell as nuclear erythroid factor -2 (Nrf-2) by significantly restoring its content. Its anti-inflammatory effects were confirmed by observing the decreasing of nuclear factor-кB (NF-кB), interleukin-1Ý (IL-1Ý) and inducible nitric oxide synthetase (iNOS) content. The anti-fibrotic effects of them were explored by assessing fibrosis related markers as they significantly reduced autotaxin (ATX), transforming growth factor Ý (TGF-Ý) and thioredoxin (Trx). Their administration significantly decreased matrix metalloproteinase-3 and 9 (MMP-3 and 9). Furthermore, they also decreased alpha smooth muscle actin (Ü-SMA) and caspase-3 as assessed immunohistochemically those results were similar to that of the standard drug UDCA. Overall result showed that SCCWE and carvacrol protect against TAA-induced liver fibrosis in rats, so they can be ascribed as a protecting natural materials from liver fibrosis
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.10.15.Ph.D.2021.Ze.C (Browse shelf(Opens below)) Not for loan 01010110084835000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.10.15.Ph.D.2021.Ze.C (Browse shelf(Opens below)) 84835.CD Not for loan 01020110084835000

Thesis (Ph.D.) - Cairo University - Faculty of Veterinary Medicine - Department of Veterinary Pharmacology

Fibrosis represents a common outcome of almost all chronic liver diseases and leads to an impairment of liver function that requires medical intervention. The current study aimed at evaluating the potential anti- fibrotic activity of saccharomyces cervisciae cell wall extract (SCCWE) and carvacrol against thioacetamide (TAA)-induced liver fibrosis in rats (200mg/ kg b.w. i.p. twice weekly for 6 weeks) using ursodeoxycholic acid (UDCA) (20 mg/kg p.o.) as a reference anti-fibrotic product. SCCWE at two doses (50 and 100 mg/kg) and carvacrol at two doses (25 and 50 mg/ kg p.o.) significantly ameliorated the rise in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamide transferase (GGT), total bilirubin (TB) and direct bilirubin (DB) and increased total protein (TP) and albumin level. SCCWE significantly reduced glutathione depletion (GSH), nitric oxide (NOX) and malondialdehyde (MDA) accumulation in liver tissue. Its anti-oxidant effects appeared by affecting markers of stress found in the cell as nuclear erythroid factor -2 (Nrf-2) by significantly restoring its content. Its anti-inflammatory effects were confirmed by observing the decreasing of nuclear factor-кB (NF-кB), interleukin-1Ý (IL-1Ý) and inducible nitric oxide synthetase (iNOS) content. The anti-fibrotic effects of them were explored by assessing fibrosis related markers as they significantly reduced autotaxin (ATX), transforming growth factor Ý (TGF-Ý) and thioredoxin (Trx). Their administration significantly decreased matrix metalloproteinase-3 and 9 (MMP-3 and 9). Furthermore, they also decreased alpha smooth muscle actin (Ü-SMA) and caspase-3 as assessed immunohistochemically those results were similar to that of the standard drug UDCA. Overall result showed that SCCWE and carvacrol protect against TAA-induced liver fibrosis in rats, so they can be ascribed as a protecting natural materials from liver fibrosis

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image